CD44 expression in cancer has been correlated with both poor and favourable outcomes [49]; however, growing evidence now suggests that overexpression of CD44 and its isoforms is an unfavourable prognostic indicator in cancer patients [50,51,52,53,54,55,56,57,58,59,60,61]. This evidence concerns the gene CD44 and cancer.